These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 12152160)
21. MicroRNA-381 represses ID1 and is deregulated in lung adenocarcinoma. Rothschild SI; Tschan MP; Jaggi R; Fey MF; Gugger M; Gautschi O J Thorac Oncol; 2012 Jul; 7(7):1069-77. PubMed ID: 22592211 [TBL] [Abstract][Full Text] [Related]
22. Down-regulation of protease-activated receptor 4 in lung adenocarcinoma is associated with a more aggressive phenotype. Jiang P; Yu GY; Zhang Y; Xiang Y; Hua HR; Bian L; Wang CY; Lee WH; Zhang Y Asian Pac J Cancer Prev; 2013; 14(6):3793-8. PubMed ID: 23886184 [TBL] [Abstract][Full Text] [Related]
23. Clinicopathological significance of core 2 beta1,6-N-acetylglucosaminyltransferase messenger RNA expressed in the pulmonary adenocarcinoma determined by in situ hybridization. Machida E; Nakayama J; Amano J; Fukuda M Cancer Res; 2001 Mar; 61(5):2226-31. PubMed ID: 11280791 [TBL] [Abstract][Full Text] [Related]
24. Suppression of anchorage-independent growth of human cancer cell lines by the TRIF52/periostin/OSF-2 gene. Yoshioka N; Fuji S; Shimakage M; Kodama K; Hakura A; Yutsudo M; Inoue H; Nojima H Exp Cell Res; 2002 Sep; 279(1):91-9. PubMed ID: 12213217 [TBL] [Abstract][Full Text] [Related]
25. Blocked expression of key genes of the angiogenic pathway in JSRV-induced pulmonary adenocarcinomas. Gomes M; Archer F; Girard N; Gineys B; Dolmazon C; Bobet Erny A; Mornex JF; Leroux C Vet Res; 2017 Nov; 48(1):76. PubMed ID: 29137669 [TBL] [Abstract][Full Text] [Related]
26. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis]. Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638 [TBL] [Abstract][Full Text] [Related]
27. [Mapping and expression analysis of a different expression cDNA fragment from lung adenocarcinoma cell line]. Fan H; Li Y; Feng HC; Lü BJ; Fu SB; Zhang GY; Li P Yi Chuan Xue Bao; 2002 Jun; 29(6):476-80. PubMed ID: 12096622 [TBL] [Abstract][Full Text] [Related]
28. Expression of high-mobility group-1 mRNA in human gastrointestinal adenocarcinoma and corresponding non-cancerous mucosa. Xiang YY; Wang DY; Tanaka M; Suzuki M; Kiyokawa E; Igarashi H; Naito Y; Shen Q; Sugimura H Int J Cancer; 1997 Feb; 74(1):1-6. PubMed ID: 9036861 [TBL] [Abstract][Full Text] [Related]
29. Genomic and proteomic analyses of vascular endothelial growth factor and insulin-like growth factor-binding protein 3 in lung adenocarcinomas. Gharib TG; Chen G; Huang CC; Misek DE; Iannettoni MD; Hanash SM; Orringer MB; Beer DG Clin Lung Cancer; 2004 Mar; 5(5):307-12. PubMed ID: 15086970 [TBL] [Abstract][Full Text] [Related]
30. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma. Chao YC; Pan SH; Yang SC; Yu SL; Che TF; Lin CW; Tsai MS; Chang GC; Wu CH; Wu YY; Lee YC; Hong TM; Yang PC Am J Respir Crit Care Med; 2009 Jan; 179(2):123-33. PubMed ID: 18787218 [TBL] [Abstract][Full Text] [Related]
31. Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells. Wesley UV; Tiwari S; Houghton AN Int J Cancer; 2004 May; 109(6):855-66. PubMed ID: 15027119 [TBL] [Abstract][Full Text] [Related]
32. NM_001013649.3 gene is down-regulated in human colorectal adenocarcinoma. Jiang Q; Zhang C; Chen Y Mol Med Rep; 2011; 4(6):1279-81. PubMed ID: 21874238 [TBL] [Abstract][Full Text] [Related]
33. Expression of thyroid transcription factor-1 in normal and neoplastic lung tissues. Nakamura N; Miyagi E; Murata S; Kawaoi A; Katoh R Mod Pathol; 2002 Oct; 15(10):1058-67. PubMed ID: 12379752 [TBL] [Abstract][Full Text] [Related]
34. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777 [TBL] [Abstract][Full Text] [Related]
35. Reduced expression of REIC/Dkk-3 gene in non-small cell lung cancer. Nozaki I; Tsuji T; Iijima O; Ohmura Y; Andou A; Miyazaki M; Shimizu N; Namba M Int J Oncol; 2001 Jul; 19(1):117-21. PubMed ID: 11408931 [TBL] [Abstract][Full Text] [Related]
36. TIMP-3 mRNA expression is regionally increased in moderately and poorly differentiated colorectal adenocarcinoma. Powe DG; Brough JL; Carter GI; Bailey EM; Stetler-Stevenson WG; Turner DR; Hewitt RE Br J Cancer; 1997; 75(11):1678-83. PubMed ID: 9184186 [TBL] [Abstract][Full Text] [Related]
37. Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas. Miller CT; Chen G; Gharib TG; Wang H; Thomas DG; Misek DE; Giordano TJ; Yee J; Orringer MB; Hanash SM; Beer DG Oncogene; 2003 Sep; 22(39):7950-7. PubMed ID: 12970743 [TBL] [Abstract][Full Text] [Related]
38. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene. Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218 [TBL] [Abstract][Full Text] [Related]
39. Loss of heterozygosity at the bcl-2 gene locus and expression of bcl-2 in human gastric and colorectal carcinomas. Ayhan A; Yasui W; Yokozaki H; Seto M; Ueda R; Tahara E Jpn J Cancer Res; 1994 Jun; 85(6):584-91. PubMed ID: 8063611 [TBL] [Abstract][Full Text] [Related]
40. Hypoxia-inducible factor-1alpha modulates the down-regulation of the homeodomain protein CDX2 in colorectal cancer. Zheng J; Sun X; Wang W; Lu S Oncol Rep; 2010 Jul; 24(1):97-104. PubMed ID: 20514449 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]